Dopamine D Receptors: Relevance for the Drug Treatment of Parkinson's Disease

ISSN： 1172-7047

Source： CNS Drugs, Vol.12, Iss.5, 1999-11, pp. : 391-402

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Dopamine D2 and Adenosine A2A Receptors: Past, Present and Future Trends for the Treatment of Parkinson's Disease

Current Medicinal Chemistry, Vol. 21, Iss. 27, 2014-09 ,pp. : 3188-3210

Bentham Science Publishers

Access to resources Recommend Favorite

Dopamine D3 Agonists in the Treatment of Parkinson&aposs Disease

Current Topics in Medicinal Chemistry, Vol. 15, Iss. 10, 2015-05 ,pp. : 908-926

Bentham Science Publishers

Access to resources Recommend Favorite

Neurotoxins and medicinals for the treatment of Parkinson’s disease. Part 2: dopamine receptors and their agonists

By Kadieva M. Oganesyan É. Mutsueva S.

Pharmaceutical Chemistry Journal, Vol. 39, Iss. 10, 2005-10 ,pp. : 520-532

Springer Publishing Company

Access to resources Recommend Favorite

The safety of dopamine agonists in the treatment of Parkinson's disease

By Bonuccelli Ubaldo Ceravolo Roberto

Expert Opinion on Drug Safety, Vol. 7, Iss. 2, 2008-03 ,pp. : 111-127

Informa Healthcare

Access to resources Recommend Favorite

Functional relevance of dopamine receptors

By Seabrook G.R. Patel S. Hutson P.H. Ragan C.I. Bristow L.J.

Trends in Pharmacological Sciences, Vol. 16, Iss. 12, 1995-12 ,pp. : 406-407

Elsevier

Access to resources Recommend Favorite